Latest Headlines

Latest Headlines

Sanaria raises $48.5M from Equatorial Guinea, oil and gas companies to develop malaria vaccine

The government of Equatorial Guinea has teamed up with Marathon Oil, Noble Energy and AMPCO to sponsor the development of the Sanaria PfSPZ vaccine against malaria. The $48.5 million in funding includes support for clinical trials from 2015 to 2018, Sanaria said in a statement.

Vax experts discuss trials, tribulations of malaria R&D;

Stephen Hoffman joined a group of vaccine development experts gathering in Washington this week to discuss their progress on a new malaria jab. But the founder of Sanaria reportedly found himself on

Sanaria starts adult trial of malaria vax

Rockville, MD-based Sanaria has launched a Phase I trial of its malaria vaccine candidate in adults. Working with the backing of the PATH Malaria Vaccine Initiative, Sanaria is recruiting 104

Malaria trials will pay volunteers to get infected

The PATH Malaria Vaccine Initiative and Seattle Biomedical Research Institute are teaming up on a new testing facility devoted to preventing malaria. When the Seattle building is complete in two